Amarin Corporation plc (AMRN) Fundamentals

Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular health. Its lead product includes Vascepa.
SHARE INFORMATION
Market Cap$ 439,494,010
Shares Outstanding403,205,514
Float394,813,409
Percent Float97.92%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 583,187,000
Latest Fiscal EPS$ 0.03
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions352
Institutional Holdings Date2022-08-31
Institutional Bought Previous 3 Months17,240,152
Institutional Holdings Percent40.0%
Institutional Sold Previous 3 Months12,794,779
Insider Holdings Date2022-08-31
Insider Bought Previous 3 Months2,106,203
Insider Holdings Percent2.1
Insider Sold Previous 3 Months247,663
Insider Shares Owned8,392,105
TRADING INFO
52 Week High$ 5.52
52 Week Low$ 1.04
52 Week High Change$ -79.96
21 Day Moving Average$ 1.2362
21 Day Extended Moving Average$ 1.2439
50 Day Moving Average$ 1.3356
50 Day Extended Moving Average$ 1.3688
200 Day Moving Average$ 2.3799
200 Day Extended Moving Average$ 2.3512
10 Day Average Volume3,090,816
20 Day Average Volume3,944,576
30 Day Average Volume3,616,301
50 Day Average Volume3,594,429
Alpha0.036873
Beta1.8723
Standard Deviation0.584818
R20.026096
7 Day Price Change$ -0.16
7 Day Percent Change-12.8%
21 Day Price Change$ -0.12
21 Day Percent Change-9.92%
30 Day Price Change$ -0.26
30 Day Percent Change-19.26%
Month to Date Price Change$ -0.09
Month to Date Percent Change-7.63%
Quarter to Date Price Change$ -0.40
Quarter to Date Percent Change-26.85%
180 Day Price Change$ -2.18
180 Day Percent Change-66.67%
200 Day Price Change$ -1.91
200 Day Percent Change-63.67%
Year to Date Price Change$ -2.28
Year to Date Percent Change-67.66%

Amarin Corporation plc (AMRN) Key Ratios

PROFITABILITY
EBIT Margin-16.2%
EBITDA Margin-15.5%
Pre-Tax Profit Margin-15.5%
Profit Margin Count-21.71%
Gross Margin71.9%
Profit Margin TOT-21.71%
INCOME STATEMENTS
Revenue$ 475,599,000
Revenue Per Share$ 1.1795
Revenue (3 Years)$ 37.61
Revenue (5 Years)$ 43.15
FINANCIAL STRENGTH
Price to Tangible Book0.80
Total Debt To Equity0.00
Int Coverage-2,094.60
Current Ratio2.00
Leverage Ratio1.60
Quick Ratio1.30
Long Term Debt To Capital0.02
VALUATION MEASURES
PE Ratio-4.40
Enterprise Value$ 136,435,010
Price to Sales0.924085
Price to Free Cash-2.20
PE High Last 5 Years-10.90
Price To Book0.80
Price To Cash Flow329.80
PE Low Last 5 Years-51.90
Price to Tangible Book0.80
MANAGEMENT EFFECTIVENESS
Receivables Turnover3.30
Invoice Turnover0.60
Assets Turnover0.50
Return Assets-10.54
Return on Equity-17.38
Return on Capital-16.16

Amarin Corporation plc (AMRN) Profile

PROFILE INFO
Issue TypeCS
SEC TypeDR
AuditorErnst & Young LLP
CEOKarim Mikhail
Emplyoees560
Last AuditUQ
CIK0000897448
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address77 Sir John Rogerson's Quay
Block C
Dublin, D02 VK60
Websitehttps://www.amarincorp.com
Facsimile-
Telephone+353 16699020
Emailinvestor.relations@amarincorp.com


Your Recent History
NASDAQ
AMRN
Amarin
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.